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Abstract
Background: Mass screening for celiac disease (CD) as a public health intervention is controversial. Prior to
implementation, acceptability to the targeted population should be addressed. We aimed at exploring adolescents’
and parents’ experiences of having the adolescents’ CD detected through mass screening, and their attitudes
towards possible future mass screening.
Methods: All adolescents (n = 145) with screening-detected CD found in a Swedish school-based screening study,
and their parents, were invited to this study about one year after diagnosis. In all, 14 focus group discussions were
conducted with 31 adolescents and 43 parents. Written narrative was completed by 91 adolescents (63%) and 105
parents (72%), and questionnaires returned by 114 parents (79%). Data were analyzed using qualitative content
analysis. In addition, narratives and questionnaire data allowed for quantified measures.
Results: Adolescents and parents described how they agreed to participate “for the good of others,” without
considering consequences for themselves. However, since the screening also introduced a potential risk of having
the disease, the invitation was regarded as “an offer hard to resist.” For the majority, receiving the diagnosis was
described as “a bolt of lightning,” but for some it provided an explanation for previous health problems, and
“suddenly everything made sense.” Looking back at the screening, the predominant attitude was “feeling grateful for
being made aware,” but some adolescents and parents also expressed “ambivalent feelings about personal benefits.”
Among parents, 92% supported future CD screening. The most common opinion among both adolescents and
parents was that future CD mass screening should be “a right for everyone” and should be offered as early as
possible. However, some argued that it should be “only for sufferers” with symptoms, whereas others were
“questioning the benefits” of CD mass screening.
Conclusions: Although the incentives to participate in the CD screening were partly non-personal, and diagnosis
was met with surprise, adolescents and parents felt grateful that they were made aware. They welcomed future CD
screening, but suggested that it should be conducted earlier in life. Thus, CD mass screening seemed acceptable
to most of those who were diagnosed and their parents.
Background
Mass screening programs seek to identify individuals at
risk of or already affected by a disease, and to offer
further tests or treatment to reduce the risk of the disease
or its complications [1]. Benefits of screening programs
should outweigh their possible harm, and the World
Health Organization (WHO) has established criteria that
should be fulfilled before implementation [2]. These cri-
teria state that the disease should constitute an important
health problem with a well understood natural history. In
addition, the screening tests, as well as the diagnostic
procedure and treatment following a positive result,
should be acceptable to the population addressed [3-5].
Population-based screening that targets apparently
healthy people raises specific ethical concerns. Indivi-
duals invited to a screening should be provided with
enough information to make an informed decision as to
whether or not to take part [5]. These prerequisites are
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comprises minors not entitled to decide by themselves
whether or not to participate.
Mass screening might be an option for reducing the
negative public health impact of untreated celiac disease
(CD) [6]. CD, also called gluten intolerance, is a chronic
multi- systemic disorder in which ingestion of gluten
triggers an autoimmune reaction resulting in villous atro-
p h yo ft h es m a l li n t e s t i n e[ 7 ] .T h ed i s e a s ei sag l o b a l
health problem with an increasing prevalence in many
settings. Screening studies in different populations have
revealed a CD prevalence varying from 3/1000 to 56/
1000, always with most cases being previously undiag-
nosed [8-12]. Clinically detected CD still may present
with gastrointestinal problems, but is increasingly also
being diagnosed in patients with subtle feelings of ill
health or other extra-gastrointestinal symptoms [13].
Among screening-detected CD patients both sympto-
matic and asymptomatic cases are found [14,15]. CD is
associated with an increased risk for developing short-
and long-term negative health consequences such as
nutritional deficiencies, anemia, delayed puberty, depres-
sion, and low bone mineral density [7]. Serological CD
markers with high sensitivity and specificity are available,
but a definitive diagnosis requires demonstration of small
intestinal histopathologic abnormalities consistent with
CD [16]. A strict gluten-free diet, i.e. exclusion of all
foods containing wheat, rye or barley, is nearly always an
effective treatment that restores the intestinal mucosa
and resolves symptoms [7].
Mass screening for CD is controversial, although most
of the screening criteria established by the WHO are ful-
filled [2,6,17-21]. Health economic evaluations are
needed, and the optimal age(s) for testing for CD is yet to
be defined. Follow-up studies of screening-detected CD
cases are scarce. We recently reported that 54% of ado-
lescents with screening-detected CD perceived improved
health one year after diagnosis and initiated treatment
[14]. Another follow-up study of screening-detected CD
children, diagnosed at 2 to 4 years of age, showed that 10
years later 66% of those following a gluten-free diet
experienced improved health [22]. However, we have also
shown that the impact of a CD diagnosis on quality of
life varies, as changes in perceived health must be
balanced against the experiences of living with CD in
terms of social sacrifices [14]. Further, other studies have
also shown that the lifelong dietary restrictions have con-
siderable effect on daily life and strict compliance is diffi-
cult to achieve [23-26].
Before implementation of a CD screening program, its
acceptability to the population concerned should be
addressed. In a study of 12-year-olds involved in a CD
screening we showed that although some children experi-
enced anxiety before receiving the test results, they had
or were provided with tools allowing them to cope well
and gain confidence [27]. However, no previous study
has explored the experiences of those who actually
receive a CD diagnosis through screening. Understanding
their perspective will help in identifying difficulties asso-
ciated with this experience and in guiding healthcare pro-
viders in their management of these patients. In this
study our aim was to explore adolescents’ and parents’
experiences of having the adolescents’ CD detected
through mass screening, as well as their attitudes towards
possible future mass screening.
Methods
Study design
The study utilized a mixed-method design including both
qualitative and quantitative methods [28]. First, we
explored informants’ perceptions and attitudes in focus
group discussions. Thereafter we constructed follow-up
questionnaires that were sent to the informants and also
included an invitation to write a narrative. Transcribed
texts from focus group discussions and written narratives
were jointly analyzed using qualitative content analysis.
In addition, narratives and questionnaire data allowed for
quantified measures.
The setting
A cross-sectional school-based CD screening study of 12-
years-olds entitled ETICS - Exploring the Iceberg of
Celiacs in Sweden - was performed in five study sites
across Sweden [8]. All sixth-graders in the participating
schools received an invitation letter containing informa-
tion about CD and the screening procedure, with one
section of the letter specifically addressed to the adoles-
cents, and another to their parents. After obtaining writ-
ten informed consent from the parents, blood samples
from the adolescents were collected at school and ana-
lyzed for CD serological markers. If the test results
showed elevated CD serological markers, the parent/s
received a telephone call from a pediatrician who gave
information and offered an appointment within a week at
the closest pediatric department. At this appointment
further information about CD was given to the adoles-
cent and parent/s and a small intestinal biopsy was
recommended. Those with biopsy results confirming a
CD diagnosis were recommended to adhere to a lifelong,
strict gluten-free diet. Support was offered including con-
sultation with a dietician and follow-up visits to a
pediatrician.
The ETICS-study has been described previously [8]. In
summary, all adolescents (n = 10041) in all sixth grade
school classes in the five study sites were invited. Blood
samples from 7208 adolescents (72%, 3467 girls, 3741
boys) without previously detected CD were analyzed for
CD serological markers (total s-IgA, antihuman tissue
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Page 2 of 12transglutaminase (tTG) of isotype IgA, and if borderline
values also for endomysial antibodies). A total of 192
adolescents (2.7%) were found to have elevated levels,
and out of those, 180 agreed to undergo a small intestinal
biopsy, resulting in 145 screening-detected CD cases
(2.0%) diagnosed by biopsy.
Study population
All adolescents with screening-detected CD found in the
ETICS study (n = 145) and their parents constituted the
recruitment basis for this study. An overview of the num-
ber of informants across the five study sites is given in
Table 1. In total, 31 adolescents and 43 parents partici-
pated in focus group discussions, 91 adolescents and 105
parents submitted a written narrative, and 114 parents
filled in questionnaires. The median age of the adolescents
contributing with narratives was 14.6 years (13.9-15.4) and
the median time since diagnosis was 15.9 months (11.1-
23.2). There were no statistically significant differences in
the proportion of girls/boys, the level of mucosal damage
of participating and non-participating adolescents or the
educational level of participating and non-participating
parents (Chi-square-test, p > 0.05).
Focus group discussions
About one year after diagnosis, all families in four of the
five study sites were informed in letters sent to their
homes about their possibility to participate in focus
group discussions. A few of them immediately replied to
confirm their participation. The others were recruited by
phone, with the aim to ensure suitable group sizes, and
t h a tb o y sa n dg i r l sa sw e l la sm o t h e r sa n df a t h e r sw e r e
represented. In total, 14 focus group discussions were
held, involving 31 adolescents and 43 parents. The main
reason given for non-participation was lack of time, but a
few adolescents also expressed reluctance to talk about
their disease. However, parents of this latter group did
participate.
Follow-up questionnaires
Follow-up questionnaires with invitations to write a nar-
rative were sent to the homes of all adolescents (n =
145) and their parents about one year after diagnosis.
Completed narratives were returned by 91adolescents
(63%) and 105 parents (72%). Questionnaires regarding
future screening were returned by 114 parents (79%).
Data collection
Focus group discussions
Adolescents and parents attended different groups but
were mixed in terms of gender. The interviewers (AR,
ME, EK) did not have a professional relationship with the
informants. A flexible topic guide and hypothetical case
stories were used to stimulate the discussions and infor-
mants were encouraged to discuss issues of greatest
importance to them to increase the likelihood that their
own accounts would take priority. The topic guide was
structured around the informants’ reasoning when decid-
ing to take part in the screening, their experiences of
receiving the diagnosis, their reflections concerning their
own experience of taking part in a screening, and their
attitudes towards CD mass screening. All interviews were
digitally recorded. The recorded files were transcribed
verbatim by an assistant, and later cross-checked by the
first author to ensure accuracy. Transcribed texts were
entered into the software Open Code [29].
Follow-up questionnaires
Short reflective narratives Along with answering fol-
low-up questionnaires, both the adolescents and their
parents were asked to write individual narratives. They
were encouraged to reflect on their overall experience of
the CD screening and specifically to elaborate both on
Table 1 Number of informants in the different data collections, across study sites
Study site CD-cases Focus group discussion Written narrative Questionnaire
Invited
b Participated Invited
b Participated Invited
c Participated
Adolescents Parents Adolescents Parents Parents
nn n nn n n n n
Umeå 16 16 8 9 16 7 10 16 10
Norrtälje 18 18 3 8 18 10 13 18 14
Norrköping 17 17 8 12 17 10 13 17 14
Lund 65 65 12 14 65 45 48 65 55
Växjö 29 0 0 0 29 19 21 29 21
Total 145
a 116 31 43 145 91 105 145 114
% females 52 54 45 60 52 53 85 52 84
% of invited – 21 –
d 63 72 79
a All screening-detected CD cases found in the multicenter CD screening, forming the recruitment basis for this study.
b Adolescents with their parent(s) were invited.
c Only parents invited.
d Not possible to calculate since we do not know the total number of parents living with the adolescents.
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recommendations about possible future CD screening.
To facilitate confidentiality between adolescents and par-
ents, they were instructed to return the questionnaires in
separate envelopes. The length of the narratives ranged
from one to two handwritten pages. All narratives were
transcribed verbatim and entered into the software Open
Code.
Questions on future screening The parental question-
naire included two questions that were utilized in this
study: i) whether a CD screening should be implemen-
ted, with pre-determined response alternatives (yes, no,
don’tk n o w ) ,a n dii) at what age a screening should be
conducted, which was an open-ended question.
Qualitative analysis
Transcribed texts from all focus group discussions and
written narratives were jointly analyzed systematically with
the aim of gaining understanding and interpreting the
meaning of the text. For this purpose we used qualitative
content analysis as described by Graneheim and Lundman
[30]. Initially the texts were read several times to obtain a
flexible frame of reference. Thereafter, all texts were
labeled with codes to conceptualize and categorize the
informants’ experiences. Coded data related to the differ-
ent content areas were gathered and compared regarding
similarities and differences. Codes sharing communalities
were grouped into sub-categories, which later supported
the constructed categories, reflecting more abstract levels
of the meaning in the informants’ accounts. As we aimed
at capturing and presenting the variation in the data, we
kept close to the informants’ own descriptions of their
experiences. An illustration of the qualitative analytical
process is presented in Figure 1. The analysis, done by the
first author but continuously discussed with the co-
authors, was characterized by constant comparison of the
sub-categories and categories with the original text to
ensure that the interpretations were grounded in the data.
Quantitative analysis
As all adolescents and parents were invited to write narra-
tives it allowed us to quantify the proportions supporting
the categories derived from the qualitative analysis. Each
individual narrative was reviewed to judge which of the
categories within each content area that were supported,
or not reflected upon. In addition we analyzed question-
naire data on parents’ attitudes towards future screening.
For analysis of quantified measures, SPSS 19.0 (SPSS Inc.,
Chicago, IL) was used.
Ethical considerations
When the adolescents were invited to the focus group
discussions, they were informed that participation was
voluntary. It was also emphasized that they should only
share things they felt comfortable about sharing. After
the sessions, a pediatrician from the research group was
available to answer questions from both adolescents and
parents. Written informed consent was obtained from
caregivers of all participating adolescents. The Regional
Ethical Review Board in Umeå, Sweden, approved the
study [Dnr UmU 04-156M].
Results
The qualitative analysis of focus group discussions and
written narratives resulted in nine categories that corre-
sponded to four different content areas: reasoning
behind participation in the screening, immediate reac-
tions to the diagnosis, looking back at the screening,
and attitudes towards future mass screening (Figure 2).
In the following text we describe results of the qualita-
tive analysis in more detail by highlighting the content
areas (headings) with the corresponding categories (sub-
headings). Quotations from focus group discussions and
written narratives show how our interpretations are
grounded in the data. As a complement, Table 2 gives the
proportions of adolescents and parents who in their narra-
tives supported the categories developed for the different
content areas. In addition, results from the questionnaire
for parents regarding their opinions about future CD
screening are presented in Table 3.
Reasoning behind participation in the screening
For the good of others
The focus group discussions revealed that the reason for
participating was mainly based on a willingness to contri-
bute to research, without considering potential personal
implications. Both adolescents and parents expressed that
they considered participation their responsibility to help
others and that they generally trusted that they would be
treated fairly in research projects.
“When it [the invitation] came it was the most
natural thing, you just had to do it for research.”
Mother, FGD
“My mother told me I should take the test. She said
we had to show them someone who is healthy. That
didn’t work very well.”
Girl, FGD
An offer hard to resist
Some adolescents also related that, the blood sampl-
ing itself became a way of proving themselves. They
described that some classmates who refused the test were
looked upon as ridiculous, but it also seemed that refusal
to participate was considered a more active way of behav-
ing than following the crowd. Thus, peer pressure
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cents. Whereas some adolescents described how they
decided for themselves to participate, others revealed
that their parents decided for them, with little option for
them to refuse.
“ I thought I would just do it for the sake of doing it,
also almost just to be in the project.”
Boy, FGD
Both adolescents and parents described that they did not
expect the test to be positive, with the exception of one
mother who already had a daughter with CD and sus-
pected that her son also suffered from it. However, once
the screening was offered and a potential risk of having
the disease was introduced, an element of insecurity was
created. This insecurity, which was more prominent
among parents than among adolescents, led to wanting
reassurance about not suffering from the disease, and
made the offer to participate in the screening hard to
resist.
“We usually contribute. In part we thought it would
be easy to get this reassurance, since we didn’t believe
we would end up here. But I suppose it’sg o o dt o
have got it [CD] confirmed, and it might also help
other people.”
Father FGD
Immediate reaction to the diagnosis
Like a bolt of lightning
For the majority, news of the diagnosis was perceived as a
bolt of lightning, illustrating that the screening test, pre-
viously considered incidental or even forgotten about,
abruptly played a big role in their lives. Some revealed that
when they received the first test results they doubted that
they were correct. Another common feeling that arose was
that the diagnosis suddenly transformed the adolescent
from being normal to being different. Parents described
how they felt that the screening took their healthy child
away from them.
“It felt really strange when I heard about it. I thought
that then there must be a lot in my class who also have
it, because I look just like all the others. So it felt kind
of strange. Have they really tested my blood samples?”
Girl, FGD
A pediatrician gave the test results to the parents
first, by phone, and the parents then were messengers
Other text segments Other codes Other sub-categories
SUB-CATEGORIES
LIKE A BOLT
OF LIGHTNING 
Girl: I was very surprised. At 
first I thought that they might 
have done wrong. But then,  
when I found out that I had it, 
then, well, at first, I thought 
that I still didn´t have it.
Girl: It felt really strange 
when you heard about it. I 
thought that then there must 
be a lot in my class who also 
have got it, because I look 
just like all the others [...]. 
Boy: At first I was like WHAT! 
But then when I found out I 
didn´t care, or I cared, but I 
did not think it really was 
much of a difference, 
because I didn´t quite 
understand what  it meant.
(Focus group discussion) 
Surprised
Loss of normality
Felt strange
Didn´t quite
understand
Didn´t care
Surprised
Still didn´t believe
A mistake?
Denial
Couldn´t be 
true
Suddenly turning 
different
Didn´t understand 
what it meant
CATEGORY CODES TEXT
Only me?
Figure 1 The process of qualitative content analysis, moving from text to an interpretation of the abstract meaning.
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cents described this as an awkward situation, because
neither they nor their parents understood what it really
meant. This lack of knowledge fostered anxiety among
both parents and adolescents.
“ [When receiving the results] I wasn’t totally sure either,
but I had a little hope that maybe it wasn’ts o ,b u tw h a t
was it then? Something even worse, I thought. THEN I
was scared about that and searched the internet and
got nightmares that it was something even worse.”
Mother, Narrative
Some adolescents described how in retrospect they felt
betrayed by the information given before the test, as they
thought it had not sufficiently prepared them for the con-
sequences of participating in the screening. They
described feelings of regret at having decided to partici-
pate, or being disappointed in their parents who decided
for them. Words like “being caught” or “getting stuck”
were frequently used when they described receiving the
diagnosis. They also emphasized that more explicit infor-
mation about the consequences of the screening should
be given before the test.
Suddenly everything made sense
Adolescents experiencing health problems before diagno-
sis, as well as their parents, described how the diagnosis
came as a relief. Some of them had sought healthcare
without CD being detected, and now with the diagnosis
they found out what the underlying problem was.
“We’d been to the pediatric clinic earlier for different
diffuse problems, so when we found out about this, it
was as if it suddenly dawned on me.”
Suddenly everything
made sense
Attitudes towards
future screening
Reasoning behind
participation
Looking back
at the screening
For the good of others
An offer hard to resist
Questioning the 
benefits
A right for everyone
Only for sufferers
Feeling grateful
for being made aware
Ambivalent feelings 
about personal benefits
Like a bolt of lightning
Immediate reaction
to the diagnosis
Figure 2 Content areas and categories derived from qualitative analysis reflecting experiences of, and attitudes towards, CD-
screening.
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Overall, boys and girls seemed to have similar reac-
tions towards receiving the diagnosis. They shared
numerous descriptions of how they reacted with anger,
anxiety, fear and sadness. Both adolescents and parents
r e l a t e dt h a tw h a tw a sh a r d e s tt oh a n d l ew a st h ef a c t
that there was no cure. However, mothers also
expressed feelings of guilt for not having suspected that
their adolescent suffered from a disease. Interestingly,
only mothers, not fathers, expressed having a guilty con-
science.
“Our daughter had begun to feel worse before the
study. She was pale, short of breath, tired and
depressed. We understood that something was wrong,
but when we received the celiac diagnosis we were
still surprised, because she hadn’t had big problems
with her stomach. As a mother and a nurse, I had a
really guilty conscience because I hadn’t understood
earlier.”
Mother, Narrative
Looking back at the screening
Feeling grateful for being made aware
Knowledge of a previously undetected diagnosis was
perceived as important in itself and adolescents and par-
ents expressed gratitude for being made aware. How-
ever, the reasons differed depending on the adolescents’
perceived health before the screening. If they had been
experiencing symptoms, becoming aware of the diagno-
sis gave them a means of feeling better. However, ado-
lescents without previous symptoms, as well as their
parents, expressed that the screening was even more
important to them, as otherwise they would not have
Table 2 Quantification of informants who in their narratives supported the categories derived from the qualitative
analysis
Content areas with related categories
a Adolescents Parents
n (%) n (%)
Immediate reaction to the diagnosis
Like a bolt of lightning 68 (75%) 73 (70%)
Suddenly everything made sense 5 (5%) 19 (18%)
Not reflected upon 18 (20%) 13 (12%)
Looking back at the screening
Feeling grateful for being made aware 35 (38%) 76 (72%)
Ambivalent feelings about personal benefits 9 (10%) 8 (8%)
Not reflected upon 47 (52%) 21 (20%)
Attitudes towards future screening
A right for everyone 62 (68%) 72 (68%)
Only for sufferers 8 (9%) 2 (2%)
Questioning the benefits 9 (10%) 8 (8%)
Not reflected upon 12 (13%) 23 (22%)
Total 91 (100%) 105 (100%)
a This table does not include content area Reasoning behind participation, since that was only asked for, and reflected upon, in the focus group discussions.
Table 3 Parental questionnaire data on attitudes towards a future celiac disease screening
Question Response-alternative Responses
n (%)
Do you think a general screening for celiac disease should be implemented in the future? Yes 105 (92%)
No 2 (2%)
Don’t know 7 (6%)
If a screening is implemented, at what age do you think it should take place? 0 - 5 years 34 (30%)
6-10 years 39 (34%)
> 10 years 12 (11%)
Don’t know 24 (21%)
Non-response 5 (4%)
Total 114 (100%)
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realizing that their adolescent had the disease led to
feelings of insecurity and worry about what could have
happened if they had not been in the screening.
“You’re happy when it’s detected. Since she wasn’t
sick, it’s even better that we found out now. It could
have gone on forever.”
Mother, narrative
Both adolescents and parents had adopted the doctor’s
argument and were concerned about future complica-
tions. Interestingly, the complications mentioned by the
informants differed in the different study sites. In some
sites the greatest concern was getting diabetes, whereas
in others cancer was mentioned as the complication of
most concern.
“I think knowing is only positive. I think it would be
worse not knowing, and risk developing all those
complications.”
Father, FGD
Having internalized the risk for future complications
functioned as a strong motivator for adhering to the glu-
ten-free diet. When asked to compare the dietary recom-
mendations with other (more general) health promoting
advice, the adolescents described how the dietary recom-
mendations became more personal, and thereby more
important to follow.
Girl A: “I think that you’re more motivated to eat
gluten-free food than not to start smoking, because
smoking still is your own choice. I mean that to eat
gluten-free is like, it’s just best for me. I mean you
almost have to do it.”
Boy B: “Well, if someone tells you to quit smoking you
don’t take it so seriously. Of course you shouldn’t
smoke, you know that, but if you get the recommenda-
tion to eat gluten-free food, then it’s more personal. At
least that’s what I think.”
Girl C: “It sort of feels more important”.
FGD
Ambivalent feelings about personal benefits
Some adolescents and parents were ambivalent about the
benefits of adhering to the dietary recommendations. This
attitude was associated with not experiencing any health
improvement and/or being ambivalent about whether
health complications really would occur if they did not
comply with the diet. This was also related to concern
about the social consequences of having to adhere to a
strict diet and to beliefs about a higher threshold for the
amount of gluten that could be tolerated. However, even
when doubt was expressed about the benefits of comply-
ing with the diet, the uncertainly of not knowing for sure
if there would be future consequences led to ambivalent
feelings about the value of the diagnosis and adhering to
the treatment.
“I got very annoyed when my doctor called and said
that I was gluten intolerant, not because I was gluten
intolerant, but because I had no symptoms. When we
said that to a dietitian, she said that I should at least
try gluten-free food for three months, and I did, but I
didn’t feel better [...] Personally, I don’t think you need
to be tested for something you don’ts u f f e rf r o m ! ”
Girl, Narrative
Attitudes towards future screening
From the parental questionnaire data we found that 92%
of the responding parents wanted a CD screening to be
implemented, whereas 2% were against it and 6%
answered that they did not know (Table 3). The majority
of parents (64%) wanted a screening to be conducted
during the period from 0-10 years of age. The analysis of
the qualitative data shed light on the reasoning behind
the attitudes of both the adolescents and the parents.
A right for everyone
This category, reflecting the most common standpoint
towards future CD mass screening among both adoles-
cents and parents, was strongly related to having interna-
lized the risk of possible negative outcomes of untreated
CD. It reflects the opinion that if society knows how to
find the disease, it is a human right to be offered the test.
The adolescents expressed a concern for people who were
still unaware of their disease and considered it unfair that
the screening study only comprised sixth graders in cer-
tain cities instead of being offered to everyone. Parents, on
the other hand, described how they could not understand
other parents not letting their adolescents participate in
the screening. There were also personal reasons for wel-
coming a screening for everyone. The adolescents hoped
that if more cases were found, the availability of gluten-
free products would increase as would efforts by scientists
to find a cure.
“ I think you should have a screening, because if it
turns out that more children have it, then maybe
scientists will make some effort so that you don’t
have to have it.”
Boy, narrative
Thus, the main argument for offering the test to
everyone was that it was important for people to
become aware. This response was sometimes based on
the informant’s experience of improved health after
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others would have the same possibility, whereas other
informants believed that a screening was even more
important for those without symptoms, since screening
w o u l db et h eo n l yw a yt oi d e n t i f yt h e i rd i s e a s e .T h e i r
opinions seemed related to a general trust that a CD
screening would only be offer e di fi ti n v o l v e dag r e a t e r
good for those involved.
“It would be good to test every child, because if they
don’t feel good, then they will be able to feel better.
That’s how it was for me.”
Girl, Narrative
“I think that people should be part of it [the screen-
i n g ]b e c a u s ey o uh a v en o t h i n gt ol o s e .I t ’sg o o dt o
know so that you don’t get sick in the future.”
Boy; FGD
A predominant opinion was that if a future CD
screening is implemented, it should be conducted earlier
in life. Adolescents thought that it would have been
easier to adjust to the gluten-free diet if the CD had
been detected earlier, so that they would not have
become accustomed to ‘all the good food’ containing
gluten. However, some advocated that the screening
should take place in the teenage period, arguing that a
young person needs to be mature enough to manage the
transition from being normal to becoming ‘a celiac’,a
transition experienced as a big step in life. Parents, on
the other hand, advocated screening as early in life as
possible with the hope of more effectively avoiding
negative consequences of undetected disease. They were
concerned that the untreated disease might influence
the child’s growth and development more negatively if
diagnosed during or after puberty. However, parents
also related that they perceived the teenage period as
being filled with so many other commitments that it
would be easier to adjust to the dietary recommenda-
tions if the diagnosis were obtained earlier. Some said
that the timing of the current screening (at 12 years of
age) was the worst possible age.
Only for sufferers
Some adolescents emphasized that although it is impor-
tant to offer a screening test, only those suffering from
symptoms should take part. This attitude was related to
not experiencing any short-term benefits of the treat-
ment themselves and a belief that testing everyone
would be superfluous and expensive for society.
“I took the test but didn’t have any symptoms. Now I
have to eat gluten-free. I just think that only those
who feel bad should be tested.”
Boy, Narrative
Questioning the benefits
Some adolescents and parents were unsure about the
potential of a future screening. They were not convinced
about the scientific basis for recommending a screening
or the benefits of adhering to the treatment in the long
run. Adolescents could also be indecisive because of
their own experience of finding it hard to adhere to the
treatment when they had no immediate health benefits,
and they did not want others to experience the same
difficulties.
“Yes, I think it might be good to test all children for
celiac disease. But on the other hand, that depends if
it turns out that there are some (like me for example)
who would have been able to eat normally and still
not get any complications, and who would needlessly
eat a gluten-free diet for the rest of their lives that
wouldn’t be good.”
Girl, Narrative
Discussion
This is, to our knowledge, the first study to explore how
adolescents and their parents experience having the ado-
lescent’s CD detected through mass screening, as well as
their opinions about future screening efforts.
The mixed-method study design allowed for an in-depth
understanding of adolescents’ and parents’ reasoning, as
well as quantified measures of the representativeness of
some of the findings in the study population. Focus group
discussions build on group interaction and can facilitate
sharing experiences, especially when attempting to elicit
children’s views [31]. The emergent design of our study
implied that the analysis from the first focus group discus-
sions helped to steer the discussions towards a deeper
exploration of details in the following groups. Preliminary
analysis of focus group discussion data guided the triangu-
lation of data collection methods by suggesting a need for
including narratives, as well as short-answer questions in
follow-up questionnaires.
A limitation of our study is that we did not gain
approval from the ethical review board to invite those
who declined participation in the screening and those
whose serological marker results were positive but who
declined further clinical investigation, a group likely to be
more negative towards mass screening than our infor-
mants. Another limitation is that our study does not
allow for exploration of differences between experiences
of receiving a screening-detected CD diagnosis in a
research study compared to a general screening program
or being diagnosed due to symptoms. It is likely that the
context of being invited to a screening study influenced
both decision-making and reactions to the diagnosis in a
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system may not. The quantified measures of the propor-
tions of individual narratives supporting different cate-
gories should of course be interpreted with caution, since
the informants might support a certain view without hav-
ing expressed it in the narratives. However, these figures
do provide information concerning what the informants
spontaneously brought up in their accounts.
We found that the reasons adolescents and parents
participated in the screening involved a feeling of duty to
contribute to research as well as a means of handling the
risk they were introduced to. Their idea that participation
would lead to greater benefits for everyone most likely
reflects societal norms to help others. These findings are
in line with results found in a previous qualitative ETICS
sub-study involving adolescents who had not yet received
their test results [27]. However, in that study the adoles-
cents felt involved, well informed and perceived that they
had a general understanding about CD. Contrary to this,
we found that some adolescents in retrospect felt not
having participated in the decision to take part in the
screening. They also felt that they had not been provided
with enough information about the possible conse-
quences of their participation and expressed a need for
improved information before the test. These results
i m p l yt h a ti ti sp r o b a b l yf i r s tw h e nd i a g n o s e dt h a tt h e
consequences are fully incorporated and detailed infor-
mation is sought. Nevertheless, this underlines the
importance of true informed consent, which is especially
challenging when approaching minors and their guar-
dians. Our findings emphasize the importance of invol-
ving children and adolescents in the information and
consent process, even if the final decision is made by
their guardians. However, the information provided when
inviting persons to CD screening programs must be
balanced to avoid unnecessary anxiety while waiting for
the test results, since the majority of those participating
in the screening will not be diagnosed with the disease.
Being surprised, feeling angry and sad, or even question-
ing if the test results were correct characterized the initial
reaction to the diagnosis. Later these feelings developed
into a belief in the benefits of becoming aware. The emo-
tional responses of denial, anger, and later acceptance cor-
respond to stages of grief first described by Elisabeth
Kübler-Ross [32]. As most adolescents and parents had no
suspicion about the disease, they felt unprepared. Lack of
sufficient preparation for receiving “bad news” has also
been observed in studies of other screening-detected diag-
noses [33,34]. Having a moderate amount of concern prior
to a stressful event (proactive coping) is suggested to facili-
tate the psychological adaptation once the event occurs
[35]. As a screening-detected diagnosis is often unexpected,
and the transition from being healthy to becoming a
patient is abrupt, this probably influences the psychological
adaptation process negatively. Healthcare providers there-
fore need to be sensitive to what screening-detected
patients actually know about their disease, and how they
cope with the diagnosis, in order to provide adequate sup-
port and follow-up care. However, in our study we also
found that for some informants, mainly parents, the diag-
nosis actually decreased anxiety and was perceived as a
relief, since it provided an explanation for the symptoms
that were experienced. These results are supported by
other studies showing that among screening-detected CD
cases true symptomatic cases are also found [15,36]. Over-
all, boys and girls seemed to have similar reactions towards
receiving the diagnosis. However, we found that mothers,
compared to fathers, were more prone to express feelings
of guilt for not previously having suspected what their
child was suffering from. This gender difference in parental
coping has been observed in other studies [37,38].
The screening seemed acceptable to most of the ado-
lescents and their parents. They felt grateful for becom-
ing aware, based on experiences of improved health
after initiated treatment or an adaptation of the risks of
what otherwise could have happened. In fact, those who
were asymptomatic before diagnosis, and their parents,
seemed even more prone to advocate screening, as it
would be the only way to identify their disease. We also
observed that the individual doctor’s view of risk
strongly influenced the informants since the risks men-
tioned differed between study sites. The informants’
accounts reflect how the screening itself produced con-
cerns, resulting in an increased risk awareness during
the screening process. Implementation of screening pro-
grams in society as a means of preventing complications
could be seen as part of the modern risk society
described by Beck [39]. In our study, some informants
had ambivalent feelings about the personal benefits.
According to Beck this can be seen as a consequence of
the modern risk society where increased awareness of
risk is followed by an increased capability to question
the suggested risks. It is often people themselves who
start to reflect on risks, since it become harder to rely
on scientists to do this for them.
A common argument against CD screening is that strict
compliance with a gluten-free diet is hard to achieve in
symptomatic CD patients, and even harder in those pre-
sumed to be asymptomatic [18,40]. Indeed, we found that
experiencing health improvements after initiating the glu-
ten-free diet functioned as a motivator for adherence.
However, even if the adolescent’s health had not
improved, most adolescents and parents expressed that
avoiding future health complications motivated dietary
compliance. In addition, adhering to the diet was per-
ceived as more important than following health promotion
messages aimed at society as a whole, since CD was per-
ceived as more of a personal threat.
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screening but thought it should be implemented earlier
than in the present screening. Previous studies have
shown that compliance with a gluten-free diet among
adolescents is higher when CD is diagnosed earlier in life
due to symptoms [41]. However, a crucial factor in decid-
ing the optimal age (or ages) involves obtaining a balance
between identifying the majority of cases, and not having
to repeat the screening many times. It is now evident
that CD can develop at any age; however, the age distri-
bution for disease initiation (sero-conversion) is not yet
known. Thus, multi-country birth cohort studies with
repeated blood-sampling for analysis of CD serological
markers are needed, and such studies are underway [42].
In our study, some informants questioned the benefits of
the CD screening and asked for more scientific evidence
about the consequences of exposing the population to a
mass screening. However, most adolescents and parents
responded that if there are means to find the disease, then
everyone should have the right to be offered the test.
Screening to identify undiagnosed CD was seen as benefi-
cial for health outcomes, but the diagnosis was also impor-
tant in itself. The latter finding relates to the ethical
considerations introduced by genetic screening tests that
are increasingly advocated, where preventive measures are
sometimes not available [43]. If information about a diag-
nosis (or carrier status) is alone viewed as a right and as
sufficient for advocating screening, some of the currently
accepted principles for screening will be ruled out. Thus,
the challenge with mass screening is that the presumed
“right to know” must be balanced against the principle of
non-maleficence, and the autonomy of individuals with a
right to choose not to know.
Before implementing a mass screening for CD we
need to ensure that the potential benefits outweigh the
harm (and costs) both for involved individuals and
society. Many of the suggested mass screening criteria
are fulfilled for CD, but not yet all of them. Further
research is needed to evaluate the extent to which treat-
ment of screening-detected CD reduces long-term nega-
tive health consequences. In addition, health economic
evaluations are needed specifically for CD mass screen-
ing, but also allowing for comparison with other public
health interventions. We have taken a first step to
increase the understanding of CD screening acceptability
from the perspective of newly diagnosed adolescents and
their parents in a Swedish context. We believe that
some of our results are transferable to screenings in
other settings, and for other diseases. Nevertheless, addi-
tional studies on the acceptability of CD screening are
needed that involve other age groups and cultural set-
tings, as well as those individuals found to have normal
and false positive results in a screening.
Conclusions
This study contributes increased understanding concern-
ing the acceptability of a CD screening among Swedish
adolescents with CD detected through screening and
their parents. Although the incentive to participate was
found to be non personal benefits, and the diagnosis was
met with surprise, the most predominant reaction was a
feeling of gratitude for being made aware of the diagno-
sis. Although some adolescents and parents were more
reluctant regarding screening, the most predominant
view was that screening for everyone would be welcomed,
with the argument that if we know how to detect the dis-
ease, being offered the test is a human right.
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